Default: Neoplasia

ISSN: 1522-8002

Journal Home

Journal Guideline

Neoplasia Q1 Unclaimed

Neoplasia Press Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neoplasia is a journal indexed in SJR in Cancer Research with an H index of 124. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cancer, tumors, oncology research, medicine. It has an SJR impact factor of 2,414 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

WOS DOAJ Scopus
Categories: Cancer Research (Q1)
Price

2250 €

Gold OA

-

Green OA

- €

Non OA

Metrics

Neoplasia

2,414

SJR Impact factor

124

H Index

99

Total Docs (Last Year)

278

Total Docs (3 years)

4651

Total Refs

1403

Total Cites (3 years)

269

Citable Docs (3 years)

5,52

Cites/Doc (2 years)

46,98

Ref/Doc

Aims and Scope


Cancer Tumors Oncology research Medicine


Best articles

Aberrant Methylation of the Maspin Promoter Is an Early Event in Human Breast Cancer

View more

American Brain Tumor Association: Sharing Knowledge, Sharing Hope

View more

Art Of The Brain: UCLA Neuro-Oncology Program

View more

Concern Foundation: Funding Cancer Research Worldwide

View more

Editorial

View more

Implications of Mapping the Human Telomerase Gene (hTERT) as the Most Distal Gene on Chromosome 5p

View more

Inhibition of Tumor Growth, Angiogenesis, and Microcirculation by the Novel Flk-1 Inhibitor SU5416 as Assessed by Intravital Multi-fluorescence Videomicroscopy

View more

Kidney Cancer Association

View more

Microtubule-Targeting Drugs Induce Bcl-2 Phosphorylation and Association with Pin1

View more

National Childhood Cancer Foundation

View more

National Foundation for Cancer Research

View more

Neoplasia profile: American Institute for Cancer Research

View more
SHOW MORE ARTICLES

Neoplasia: Where We Have Been and Where We Are Going

View more

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors

View more

Profile - American Cancer Society

View more

The Association for International Cancer Research

View more

The Cure for Lymphoma Foundation

View more

The G&P Foundation for Cancer Research

View more

The Hypercoagulable State of Malignancy: Pathogenesis and Current Debate

View more

The International Myeloma Foundation

View more

The National Brain Tumor Foundation: Giving Help, Giving Hope

View more

The V Foundation for Cancer Research

View more

Tumor-Targeted Hyaluronan Nanoliposomes Increase the Antitumor Activity of Liposomal Doxorubicin in Syngeneic and Human Xenograft Mouse Tumor Models

View more

Comments

No comments ... Be the first to comment!